Invention Grant
- Patent Title: Beta-lactamase inhibitors
-
Application No.: US15922376Application Date: 2018-03-15
-
Publication No.: US10294248B2Publication Date: 2019-05-21
- Inventor: Christopher J. Burns , Denis Daigle , Bin Liu , Daniel McGarry , Daniel C. Pevear , Robert E. Lee Trout
- Applicant: VenatoRx Pharmaceuticals, Inc.
- Applicant Address: US PA Malvern
- Assignee: VenatoRx Pharmaceuticals, Inc.
- Current Assignee: VenatoRx Pharmaceuticals, Inc.
- Current Assignee Address: US PA Malvern
- Agency: Wilson Sonsini Goodrich & Rosati
- Main IPC: C07F5/02
- IPC: C07F5/02 ; A61K31/69 ; A61K45/06

Abstract:
Described herein are compounds and compositions that modulate the activity of beta-lactamases. In some embodiments, the compounds described herein inhibit beta-lactamase. In certain embodiments, the compounds described herein are useful in the treatment of bacterial infections.
Public/Granted literature
- US20180273552A1 BETA-LACTAMASE INHIBITORS Public/Granted day:2018-09-27
Information query